Lessons Learned from the U.S. Public Health Response to the 2022 mpox Outbreak.

gay and bisexual men mpox public health vaccine

Journal

LGBT health
ISSN: 2325-8306
Titre abrégé: LGBT Health
Pays: United States
ID NLM: 101616707

Informations de publication

Date de publication:
Oct 2023
Historique:
pubmed: 1 8 2023
medline: 1 8 2023
entrez: 1 8 2023
Statut: ppublish

Résumé

In mid-2022, an mpox outbreak occurred in the United States and more than 100 countries, disproportionately affecting men who have sex with men (MSM). Initially, the U.S. public health system failed to deploy tests, treatment, and vaccines effectively. Key federal policy changes in August 2022, along with risk reduction among many MSM, led to a steady reduction in new diagnoses by December 2022. Mpox outbreaks occurred among MSM in Chicago and France in May 2023, and vaccination rates remain low. This perspective analyzes the U.S. response to the 2022 outbreak, and it identifies the lessons learned that may guide mpox management moving forward.

Identifiants

pubmed: 37527421
doi: 10.1089/lgbt.2022.0274
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

489-495

Auteurs

Sean Cahill (S)

Health Policy Research, The Fenway Institute, Fenway Health, Boston, Massachusetts, USA.
Department of Health Law, Policy and Management, Boston University School of Public Health, Boston, Massachusetts, USA.
Department of Health Sciences, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.

Classifications MeSH